Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/1JK stock hub

FRA/1JK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/1JKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.5B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/1JK
In the news

Latest news · FRA/1JK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E38.6
P25 n/aP50 n/aP75 n/a
ROE46
P25 n/aP50 n/aP75 n/a
ROIC37.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/1JK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
176
Groups with data
11
Currency
USD
Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
736
Employees Change
29%
Employees Change Percent
4.08
Enterprise value
EUR 4.5B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 4.5B
Price
EUR 34.27
Price currency
EUR
Rev Per Employee
1,302,458.35x
Sic
2836
Symbol
fra/1JK
Website
https://apellis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
2.59%
EV Earnings
39.12x
EV/EBIT
32.21x
EV/EBITDA
30.04x
EV/FCF
139.16x
EV/Sales
4.82x
FCF yield
0.73%
P/B ratio
12.4x
P/E ratio
38.61x
P/S ratio
4.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
14.95%
EBITDA Margin
15.08%
FCF margin
3.39%
Gross margin
64.28%
Gross Profit
EUR 616.2M
Gross Profit Growth
125.78%
Gross Profit Growth Q
227.68%
Net Income
EUR 115.6M
Pretax Margin
12.23%
Profit Margin
12.06%
Profit Per Employee
EUR 157,044
ROA
10.93
Roa5y
-26.43
ROCE
20.68
ROE
46.02
Roe5y
-220.1
ROIC
37.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
111.57%
Cagr3y
-25.38%
Cagr5y
-2.15%
Revenue Growth
42.46x
Revenue Growth Q
60.85x
Revenue Growth3 Y
118.55x
Revenue Growth5 Y
34.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 1.17
Assets
EUR 938.9M
Cash
EUR 352.3M
Current Assets
EUR 871.7M
Current Liabilities
EUR 240.4M
Debt
EUR 412.6M
Debt EBITDA
EUR 2.68
Debt Equity
EUR 1.15
Debt FCF
EUR 12.7
Equity
EUR 359.9M
Interest Coverage
3.79
Liabilities
EUR 579M
Long Term Assets
EUR 67.2M
Long Term Liabilities
EUR 338.7M
Net Cash
EUR -60.3M
Net Cash By Market Cap
EUR -1.35
Net Debt EBITDA
EUR 0.42
Net Debt Equity
EUR 0.17
Net Debt FCF
EUR 1.86
Tangible Book Value
EUR 359.9M
Tangible Book Value Per Share
EUR 2.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.63
Inventory Turnover
3.47
Net Working Capital
EUR 380.8M
Quick ratio
3
Working Capital
EUR 645.8M
Working Capital Turnover
EUR 1.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-5.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
111.47%
200-day SMA
21.1
3Y total return
-58.46%
50-day SMA
25.44
50-day SMA vs 200-day SMA
50over200
5Y total return
-10.29%
All Time High
87.5
All Time High Change
-60.83%
All Time High Date
2023-06-14
All Time Low
13.88
All Time Low Change
146.9%
All Time Low Date
2025-05-16
ATR
0.5
Ch YTD
65.84
High
34.27
High52
35.81
High52 Date
2026-03-31
High52ch
-4.3%
Low
34.27
Low52
13.88
Low52 Date
2025-05-16
Low52ch
146.9%
Ma50ch
34.73%
Price vs 200-day SMA
62.4%
RSI
71.78
RSI Monthly
55.09
RSI Weekly
72.58
Sharpe ratio
0.98x
Sortino ratio
3.47
Total Return
-5.48%
Tr YTD
65.84
Tr1m
-0.75%
Tr1w
0.09%
Tr3m
87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 143.3M
Operating margin
14.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
83,206,411%
Shares Insiders
3.37%
Shares Institutions
73.19%
Shares Qo Q
3.76%
Shares Yo Y
5.48%
Short Ratio
2.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
EUR -55.8M
Average Volume
0x
Bv Per Share
2.81
CAPEX
EUR -264,527
Ch1m
-0.75
Ch1w
0.09
Ch1y
111.5
Ch3m
87
Ch3y
-58.46
Ch5y
-10.29
Ch6m
108.8
Change
-0.17%
Change From Open
0
Close
34.33
Days Gap
-0.17
Depreciation Amortization
1,189,690.7
Earnings Date
2026-05-11
EBIT
EUR 143.3M
EBITDA
EUR 144.5M
EPS
EUR 0.89
F Score
6
FCF
EUR 32.5M
FCF EV Yield
0.72x
Financing CF
7,522,960
Fiscal Year End
December
Founded
2,009
Graham Number
7.42891
Graham Upside
-78.32
Income Tax
EUR 1.6M
Investing CF
-264,527
Is Primary Listing
0
Last Earnings Date
2026-02-25
Last Report Date
2026-03-31
Ma150
21.24
Ma150ch
61.34%
Ma20
34.15
Ma20ch
0.34%
Net CF
40,676,370
Next Earnings Date
2026-05-11
Open
34.27
P FCF Ratio
137.3
P OCF Ratio
136.2
Ppne
17,267,050.2
Price Date
2026-05-08
Price EBITDA
EUR 30.88
Ptbv Ratio
12.4
Relative Volume
20x
Revenue
958,609,344x
SBC By Revenue
9.21x
Share Based Comp
88,292,875
Tax By Revenue
0.17x
Tax Rate
1.39%
Tr6m
108.79%
Z Score
0.95
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/1JK pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/1JK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+111.5%
S&P 500 1Y: n/a
3Y total return
-58.5%
S&P 500 3Y: n/a
5Y total return
-10.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/1JK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+73.2%
Share of float held by funds and institutions
Insider ownership
+3.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.8 days to cover
Y/Y dilution
+5.5%
Negative means the company is buying back shares.
Technical

FRA/1JK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
71.8
Above 70: short-term overbought
Price vs 200-day MA
+62.4%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.98
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/1JK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/1JK stock rating?

fra/1JK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/1JK analysis?

The full report lives at /stocks/fra/1JK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/1JK?

The latest report frames fra/1JK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/1JK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.